Epigenetics is the structural changes in chromosomal regions, which signal or perpetuate alteration in gene expression by turning it on or off. Epigenetic alteration includes DNA methylation, histone modification, chromatin remodeling, genomic imprinting, X chromosome inactivation, and non-coding RNA regulation affecting gene transcription. Epigenetics is applied for the studies of oncology, developmental biology, drug development, and non-oncological disorders such as Alzheimer’s disease and respiratory disease. Epigenetics has applications in in forensic science for paternity testing, distinguishing between identical twins, identification of tissue origin, and for estimation of postmortem interval. Increasing application of epigenetics is expected to propel growth of the epigenetics market.

Download PDF Brochure of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1772

Epigenetics Market Drivers

Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics platform and ongoing ProSTAR and ORIOn-E trials, which are designed to demonstrate the potential for CPI-1205 and CPI-0610, used for cancer therapy. Moreover, increasing whole genome sequencing projects such as Human Genome Project is resulting into increasing adoption of epigenetic-based products, which in turn is driving growth of the epigenetics market size.

Epigenetics Market Restraint

High maintenance and cost of the instruments such as next generation sequencing or qPCR, implemented for epigenetic study are expected to be the key factors hindering growth of the epigenetics market.

Epigenetics Market - Regional Analysis

On the basis of geography, global epigenetics market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America epigenetics market is expected to hold dominant position in the global market, owing to increasing funding for research and development activities by government. Furthermore, Asia Pacific epigenetics market is expected to be fastest growing region owing to high incidence of cancer. For instance, according to article in Japanese Journal of Clinical Oncology in 2012, more than 70% of total cancer mortality is reported in Asia Pacific region and it is projected to rise continuously to 16 million by 2025.

Epigenetics Market – Competitor

Epigenetics market is highly fragmented. Major players operating in market include Illumina Inc., Thermo Fisher Scientific Inc., Merck Millipore Limited, Bio-Rad Laboratories, Inc., Qiagen Inc., Zymo Research Corporation, Diagenode s. a., Enzo Life Sciences, Inc. and New England Biolabs Inc.

Speak To Analyst:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1772

Epigenetics Market Taxonomy

By Product
• Consumables
◦ Enzymes
◦ Kits & Reagents
• Instruments

By Application
• Oncology
• Developmental Biology
• Drug Development
• Metabolic diseases
• Other

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]